In breast cancer, upregulated FUT8 remodels TGF-β RI and RII complexes to promote downstream signalling, and genetic or pharmacological interruption of FUT8 inhibits TGF-β signalling and suppresses breast cancer metastasis in vivo [30]. The gene discussed is FUT8; the disease is breast carcinoma.